Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Khiron Life Sciences Corp. KHRNF

Set alert

Price alert · KHRNF

All alert types
0.00 USD 0.00 0.00%

At close · Oct 29

0.000001 Day range 0.000001
0.00001 52-week range 0.00001
YTD
0.00%
1 year
0.00%
Open
0.000001
Prev close
0.00001
Mkt cap
2.32K
Vol
15.04K
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
0.000001
High
0.000001

5D chart

Chart tools
Interval
1m5m15m30m

Financial health

Altman Z-Score

-5.25 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -1.0×
FY 2012: -12.3×FY 2013: -0.6×FY 2014: -1.9×FY 2015: -2.1×FY 2016: -3.6×FY 2017: -7.0×FY 2018: -3.7×FY 2019: -2.9×FY 2020: -1.9×FY 2021: -1.0×
FY 2012 5y median -2.9× FY 2021
P/S 2.7×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 82.8×FY 2019: 11.1×FY 2020: 5.7×FY 2021: 2.7×
FY 2012 5y median 5.7× FY 2021
P/B 1.0×
FY 2012: 0.3×FY 2013: 0.7×FY 2014: 8.4×FY 2015: 48.9×FY 2016: -2.2×FY 2017: 234×FY 2018: 2.9×FY 2019: 1.5×FY 2020: 0.7×FY 2021: 1.0×
FY 2012 5y median 1.5× FY 2021
P/FCF -1.5×
FY 2012: -34.7×FY 2013: -1.0×FY 2014: -1.7×FY 2015: -2.5×FY 2016: -3.6×FY 2017: -1483×FY 2018: -4.0×FY 2019: -3.0×FY 2020: -1.7×FY 2021: -1.5×
FY 2012 5y median -3.0× FY 2021
EV/EBITDA -0.9×
FY 2012: 26.9×FY 2013: 0.4×FY 2014: -1.2×FY 2015: -2.1×FY 2016: -3.5×FY 2017: -7.0×FY 2018: -3.4×FY 2019: -2.8×FY 2020: -1.2×FY 2021: -0.9×
FY 2012 5y median -2.8× FY 2021
EV/Sales 2.2×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 68.8×FY 2019: 10.5×FY 2020: 3.3×FY 2021: 2.2×
FY 2012 5y median 3.3× FY 2021
FCF Yield -64.5%
FY 2012: -2.9%FY 2013: -104.6%FY 2014: -60.3%FY 2015: -39.7%FY 2016: -27.8%FY 2017: -0.1%FY 2018: -25.2%FY 2019: -33.9%FY 2020: -59.9%FY 2021: -64.5%
FY 2012 5y median -33.9% FY 2021

Profitability

Gross Margin 49.8%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 33.3%FY 2019: 25.4%FY 2020: 87.4%FY 2021: 49.8%
FY 2012 5y median 33.3% FY 2021
Operating Margin -154.6%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -2231.3%FY 2019: -390.6%FY 2020: -294.4%FY 2021: -154.6%
FY 2012 5y median -294.4% FY 2021
Net Margin -258.9%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: -2221.3%FY 2019: -379.6%FY 2020: -299.8%FY 2021: -258.9%
FY 2012 5y median -299.8% FY 2021
ROE -99.4%
FY 2012: -2.8%FY 2013: -116.4%FY 2014: -453.4%FY 2015: -2329.9%FY 2016: 61.5%FY 2017: 0.0%FY 2018: -77.6%FY 2019: -51.9%FY 2020: -38.0%FY 2021: -99.4%
FY 2012 5y median -51.9% FY 2021
ROIC -54.1%
FY 2012: -2.8%FY 2013: -116.4%FY 2014: -453.4%FY 2015: -2329.9%FY 2016: 61.5%FY 2017: 0.0%FY 2018: -58.7%FY 2019: -50.6%FY 2020: -35.3%FY 2021: -54.1%
FY 2012 5y median -50.6% FY 2021
ROA -78.4%
FY 2012: -2.6%FY 2013: -98.0%FY 2014: -106.3%FY 2015: -329.8%FY 2016: -880.6%FY 2017: 0.0%FY 2018: -49.1%FY 2019: -44.4%FY 2020: -32.8%FY 2021: -78.4%
FY 2012 5y median -44.4% FY 2021

Growth (YoY)

Revenue 59.6%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 974.6%FY 2020: -16.3%FY 2021: 59.6%
FY 2012 FY 2021
Operating Income 16.2%
FY 2012: 0.0%FY 2013: -2526.3%FY 2014: 39.6%FY 2015: 7.7%FY 2016: 48.6%FY 2017: 100.0%FY 2018: 0.0%FY 2019: -88.1%FY 2020: 36.9%FY 2021: 16.2%
FY 2012 FY 2021
EPS (diluted) 0.0%
FY 2012: 0.0%FY 2013: -1993.4%FY 2014: 66.9%FY 2015: -2.0%FY 2016: 38.0%FY 2017: 47.3%FY 2018: -150.9%FY 2019: 12.2%FY 2020: 44.4%FY 2021: 0.0%
FY 2012 FY 2021
Free Cash Flow 18.7%
FY 2012: 0.0%FY 2013: -4456.2%FY 2014: -9.4%FY 2015: 31.2%FY 2016: 39.6%FY 2017: 63.4%FY 2018: -87202.2%FY 2019: -94.5%FY 2020: 24.7%FY 2021: 18.7%
FY 2012 FY 2021

Financial Health

Current Ratio 3.1×
FY 2012: 11.8×FY 2013: 6.3×FY 2014: 1.3×FY 2015: 1.2×FY 2016: 0.1×FY 2017: 11.7×FY 2018: 3.6×FY 2019: 5.3×FY 2020: 5.0×FY 2021: 3.1×
FY 2012 5y median 5.0× FY 2021
Quick Ratio 1.9×
FY 2012: 11.8×FY 2013: 6.3×FY 2014: 1.3×FY 2015: 1.2×FY 2016: 0.1×FY 2017: 11.7×FY 2018: 3.6×FY 2019: 5.2×FY 2020: 3.8×FY 2021: 1.9×
FY 2012 5y median 3.8× FY 2021
Debt / Equity 0.1×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.0×FY 2021: 0.1×
FY 2012 5y median 0.1× FY 2021
Net Debt / EBITDA 0.2×
FY 2012: 39.2×FY 2013: 1.0×FY 2014: 0.7×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.7×FY 2019: 0.2×FY 2020: 0.8×FY 2021: 0.2×
FY 2012 5y median 0.2× FY 2021
Interest Coverage -44.5×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: -50.4×FY 2021: -44.5×
FY 2012 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31